Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of the combination of CORT125134, a novel
glucocorticoid receptor (GR) antagonist, and nab- paclitaxel in patients with solid tumors
and to determine the preliminary efficacy of the combination of CORT125134 and
nab-paclitaxel. The structure for the study is a single arm, non-randomized, open- label,
multicenter trial with no control group.